Summary - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Ardmore Shipping Corporation

ASC

Valuace

Růst

Zdraví

Cena

$ 15.25

+0.09 (0.74%)

Kapitalizace

0.5B

Obrat

Zisk

Aktiva

Dluh

ROE

ROA

Cena 1R

8-14

⌀ Cena

10.96

Dividenda

0.0(0.0%)

Nadcházející oznámení zisků

Poslední dividenda

27-02-2026

Profil

Ardmore Shipping Corporation se zabývá námořní přepravou ropných produktů a chemikálií po celém světě. K 15. únoru 2022 společnost provozovala flotilu 25 tankerů s dvojitým trupem a chemickými tankery. Slouží ropným společnostem, ropným společnostem, obchodníkům s ropou a chemikáliemi, chemickým společnostem a poskytovatelům sdružovacích služeb. Společnost byla založena v roce 2010 a sídlí v Pembroke na Bermudách.

Sektor

Industrials

Odvětví

Marine Shipping

Počet zaměstnanců

Založení

2013-08-01

Adresa

Belvedere Building

CEO

Gernot Ruppelt

Web

ardmoreshipping.com

Podobné společnosti

Safe Bulkers, Inc.

$ 4.93

+ $ 0.15

ESEA

Euroseas Ltd.

$ 59.26

+ $ 1.35

PANL

Pangaea Logistics Solutions, Ltd.

$ 6.27

+ $ 0.45

SWBI

Smith & Wesson Brands, Inc.

$ 8.63

- $ 0.01

Zahraniční články

ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

17:05 31-03-2026

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases wi...

Ardmore Shipping Files 2025 Annual Report on Form 20-F

17:50 06-03-2026

HAMILTON, Bermuda, March 6, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore"...

Brokerages Set Ardmore Shipping Corporation (NYSE:ASC) Target Price at $13.67

1:58 16-02-2026

Ardmore Shipping Corporation (NYSE: ASC - Get Free Report) has been given a consensus recommendation...

Ardmore Shipping Corporation (ASC) Analyst/Investor Day Transcript

16:04 12-02-2026

Ardmore Shipping Corporation (ASC) Analyst/Investor Day Transcript...

Ardmore Shipping Corporation Announces Financial Results For The Three and Twelve Months Ended December 31, 2025

8:00 12-02-2026

HAMILTON, Bermuda, Feb. 12, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore"...

Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development

18:15 10-02-2026

- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets...

Sagimet Announces Positive 52-Week Data from License Partner Ascletis' Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne

7:00 02-02-2026

SAN MATEO, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clin...

Ardmore Shipping Announces 2026 Investor Day in New York

16:15 29-01-2026

The Company will present an overview of its strategy and capital allocation framework, along with an...

Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne

6:00 29-01-2026

- Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favor...

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

19:10 25-01-2026

- Topline data from the Phase II study for the treatment of diabetes are expected in the third qua...

Ardmore Shipping Corporation (NYSE:ASC) Receives $13.67 Consensus Price Target from Brokerages

1:31 22-01-2026

Shares of Ardmore Shipping Corporation (NYSE: ASC - Get Free Report) have earned a consensus rating ...

Ardmore Shipping (NYSE:ASC) Stock Crosses Below 50 Day Moving Average – Time to Sell?

4:12 10-01-2026

Ardmore Shipping Corporation (NYSE: ASC - Get Free Report) shares passed below its fifty day moving ...

Ardmore Shipping Corporation: A Modern Fleet Trading At A Discount

5:38 06-01-2026

I rate Ardmore Shipping Corporation a buy, citing a modern fleet, strong balance sheet, and discount...

Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

4:00 15-12-2025

- The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hour...

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment

4:15 10-12-2025

-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) ...

American Century Companies Inc. Grows Holdings in Ardmore Shipping Corporation $ASC

3:20 03-12-2025

American Century Companies Inc. boosted its stake in Ardmore Shipping Corporation (NYSE: ASC) by 4.4...

Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development

18:30 12-11-2025

- Using Asclet i s' proprietary U ltra- L ong- A cting P latform technology, co-formulation of ASC...

Ardmore Shipping Corporation (ASC) Q3 2025 Earnings Call Transcript

11:51 05-11-2025

Ardmore Shipping Corporation ( ASC ) Q3 2025 Earnings Call November 5, 2025 10:00 AM EST Company Par...

Ardmore Shipping Corporation Announces Financial Results For The Three and Nine Months Ended September 30, 2025

8:00 05-11-2025

HAMILTON, Bermuda , Nov. 5, 2025 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore"...

Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025

19:10 04-11-2025

-Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mea...

Výsledovka

Rozvaha

Peněžní toky